Encysive To Evaluate Options
Encysive has brought in Morgan Stanley to evaluate options. Let me translate that. They are going to be up for sale but they need to slash expenditures to make them look better.
Morgan Stanley to help Encysive evaluate options - Houston Business Journal
Here’s the interesting quote from this article.
Encysive (NASDAQ: ENCY) said it will give no more information about its review of alternatives until it agrees to a transaction, and added that there was no guarantee an alternative would be pursued.
This sort of attitude along with insisting on a formal resolution dispute I think says a lot about the companies approach. I think they will have a hard time finding suitors and if anyone is interested, it will likely be for pennies on the dollar.
Take a look at the stock price recently.
Looking at Encysive in Google trends reveals some interesting points.
There were more searches in Switzerland related to Encysive than there were in the US. Here’s why.
Thelin would go up against Allschwil, Switzerland-based Actelion Ltd.’s Tracleer (bosentan), the only approved endothelin agonist for PAH, which won clearance in Europe four years ago and was cleared in the U.S. in November 2001.
I’m not sure what will happen but I can guarantee it isn’t going to be good. There will be no phoenix rising from the ashes.
Other Resources
encysive - Yahoo! Search Results
encysive - Google Search
encysive - Google Blog Search
IceRocket Blog Search: encysive
Yahoo! News Search Results for encysive
encysive - Google News
Technorati Tags: Encysive
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
July 20th, 2007 at 9:03 pm
I believe ENCY has a very competitive product for the marketplace.
It has shown to be clinically superior to Tracleer.
Gilead Sciences drug Letairis (Ambrisentan) has a terrible black box warning and the subjects for the clinical trial were carefully chosen for success with is why they must do a follow up trial.
Read what doctors are telling their patients at a PAH support website: http://www.phassociation.org/Message_Boards/detail.asp?Id=90108